|
MRI News Service:
'Contrast' p5 |
|
|
|
 |
 | | | ''Gadolinium-based contrast agents (GBCAs) are widely used in medical imaging to provide essential diagnostic information from magnetic resonance imaging (MRI) scans. These injections help ...' | | Thursday, 30 January 2020 by www.itnonline.com |
|
|
|
| | | ''Latest release from SMI with title Contrast Agents for Magnetic Resonance Imaging (MRI) Market Research Report 2019-2026 (by Product Type, End-User / Application and Regions / Countries) provides ...' | | | Sunday, 29 December 2019 by bulletinline.com | |
|
|
|
| | | ''The U.S. Food and Drug Administration (FDA) has approved Clariscan, a macrocyclic, ionic, gadolinium-based, magnetic resonance imaging (MRI) contrast agent, expanding the GE Healthcare portfolio ...' | | | Monday, 4 November 2019 by www.itnonline.com | |
|
|
|
| | | ''Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are now commercially available, according to John Karis, M.D., director ...' | | | Friday, 4 October 2019 by www.itnonline.com | |
|
|
|
| | | ''A concerning number of U.S. women are exposed to the MRI contrast agent gadolinium early in pregnancy, a new study reveals. In many cases, this exposure occurs before women know they're ...' | | | Tuesday, 20 August 2019 by www.upi.com | |
|
|
|
| | | ''Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in developing a new, possibly safer contrast agent for use in magnetic resonance imaging (MRI) exams. ...' | | | Thursday, 15 August 2019 by www.eurekalert.org | |
|
|
|
| | | ''This preclinical study was devised to investigate potential cellular toxicity in human neurons induced by gadolinium-based contrast agents (GBCAs) used for contrast-enhanced magnetic ...' | | | Friday, 3 May 2019 by journals.lww.com | |
|
|
|
| | | ''Gadolinium(III) complexes have been widely utilised as magnetic resonance imaging (MRI) contrast agents for decades. In recent years however, concerns have developed about their toxicity, believed ...' | | | Friday, 29 March 2019 by www.nature.com | |
|
|
|
| | | ''SPL Medical BV has received approval of the German regulatory body for pharmaceutical products BfArM, to the start of a multicenter clinical trial of Ferrotran®. This is a novel contrast ...' | | | Friday, 15 March 2019 by ferrotran.com | |
|
|
|
| | | ''Administration of a gadolinium-based contrast material is widely considered obligatory for follow-up imaging of patients with multiple sclerosis (MS). However, advances in MRI have ...' | | | Tuesday, 12 March 2019 by pubs.rsna.org | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
You can fool some of the people all of the time, and all of the people some
of the time, but you can not fool all of the people all of the time.
-
Abraham Lincoln |
|
|
News
top
